HomeNIRV • CNSX
add
Nirvana Life Sciences Inc
Previous close
$0.050
Year range
$0.010 - $0.080
Market cap
1.65M CAD
Avg Volume
633.00
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 55.77K | -64.04% |
Net income | -61.11K | 63.71% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -51.19K | 61.27% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 619.00 | -93.58% |
Total assets | 195.74K | 216.47% |
Total liabilities | 1.44M | 57.58% |
Total equity | -1.24M | — |
Shares outstanding | 48.23M | — |
Price to book | -1.67 | — |
Return on assets | -128.27% | — |
Return on capital | 11.95% | — |
Cash Flow
Net change in cash
| (CAD) | Oct 2024info | Y/Y change |
|---|---|---|
Net income | -61.11K | 63.71% |
Cash from operations | -28.67K | 59.30% |
Cash from investing | — | — |
Cash from financing | 37.62K | -2.62% |
Net change in cash | -3.46K | 89.11% |
Free cash flow | -20.80K | -1,627.17% |
About
Founded
2011
Headquarters
Website
Employees
2
